H4 antagonist 48   Click here for help

GtoPdb Ligand ID: 9879

Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Compound 48 is an orally active, selective histamine H4 receptor antagonist that was developed as a potential therapy for the pruritis and inflammation associated with atopic dermatitis [4].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 2
Topological polar surface area 84.13
Molecular weight 334.03
XLogP 2
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CNC1CN(C1)c1nc2ncc(cc2n2c1nnn2)Br
Isomeric SMILES CNC1CN(C1)c1nc2ncc(cc2n2c1nnn2)Br
InChI InChI=1S/C11H11BrN8/c1-13-7-4-19(5-7)10-11-16-17-18-20(11)8-2-6(12)3-14-9(8)15-10/h2-3,7,13H,4-5H2,1H3
InChI Key ICGICUHMULRYIQ-UHFFFAOYSA-N
Immunopharmacology Comments
H4 antagonist 48 exhibits simultaneous anti-pruritic and anti-inflammatory effects in mouse models of atopic dermatitis [4]. As a clinical lead this compound represents a viable alternative to the current use of corticosteroids and topical calcineurin inhibitors (with adjuvant antihistamine drugs administered to combat itcing) as first-line treatments for atopic dermatitis. Anti-IL-4Rα and anti-IL-31RA antibodies are also being considered as atopic dermatitis therapies, but these are administered by injection, and patient compliance could therefore be an issue with these medications.